Lambein K - Search Results

1

Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study.

Dano H, Altinay S, Arnould L, Bletard N, Colpaert C, Dedeurwaerdere F, Dessauvagie B, Duwel V, Floris G, Fox S, Gerosa C, Jaffer S, Kurpershoek E, Lacroix-Triki M, Laka A, Lambein K, MacGrogan GM, Marchió C, Martinez DM, Nofech-Mozes S, Peeters D, Ravarino A, Reisenbichler E, Resetkova E, Sanati S, Schelfhout AM, Schelfhout V, Shaaban AM, Sinke R, Stanciu-Pop CM, Stobbe C, van Deurzen CHM, Van de Vijver K, Van Rompuy AS, Verschuere S, Vincent-Salomon A, Wen H, Bouzin C, Galant C, Van Bockstal MR. Dano H, et al. Among authors: lambein k. Mod Pathol. 2020 Mar;33(3):354-366. doi: 10.1038/s41379-019-0367-9. Epub 2019 Sep 18. Mod Pathol. 2020. PMID: 31534203 Free PMC article.

2

Stromal architecture and periductal decorin are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ of the breast.

Van Bockstal M, Lambein K, Gevaert O, De Wever O, Praet M, Cocquyt V, Van den Broecke R, Braems G, Denys H, Libbrecht L. Van Bockstal M, et al. Among authors: lambein k. Histopathology. 2013 Oct;63(4):520-33. doi: 10.1111/his.12188. Epub 2013 Jul 26. Histopathology. 2013. PMID: 23889174

3

Distinguishing score 0 from score 1+ in HER2 immunohistochemistry-negative breast cancer: clinical and pathobiological relevance.

Lambein K, Van Bockstal M, Vandemaele L, Geenen S, Rottiers I, Nuyts A, Matthys B, Praet M, Denys H, Libbrecht L. Lambein K, et al. Am J Clin Pathol. 2013 Oct;140(4):561-6. doi: 10.1309/AJCP4A7KTAYHZSOE. Am J Clin Pathol. 2013. PMID: 24045554

4

2013 update of the American Society of Clinical Oncology/College of American Pathologists guideline for human epidermal growth factor receptor 2 testing: impact on immunohistochemistry-negative breast cancers.

Lambein K, Van Bockstal M, Denys H, Libbrecht L. Lambein K, et al. J Clin Oncol. 2014 Jun 10;32(17):1856-7. doi: 10.1200/JCO.2013.54.2530. Epub 2014 Apr 28. J Clin Oncol. 2014. PMID: 24778399 No abstract available.

5

Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype.

Van Bockstal M, Lambein K, Denys H, Braems G, Nuyts A, Van den Broecke R, Cocquyt V, De Wever O, Libbrecht L. Van Bockstal M, et al. Among authors: lambein k. Virchows Arch. 2014 Sep;465(3):275-89. doi: 10.1007/s00428-014-1609-3. Epub 2014 Jun 29. Virchows Arch. 2014. PMID: 24973889

6

Quality of pathology reporting is crucial for cancer care and registration: a baseline assessment for breast cancers diagnosed in Belgium in 2008.

De Schutter H, Van Damme N, Colpaert C, Galant C, Lambein K, Cornelis A, Neven P, Van Eycken E. De Schutter H, et al. Among authors: lambein k. Breast. 2015 Apr;24(2):143-52. doi: 10.1016/j.breast.2014.12.004. Epub 2015 Jan 5. Breast. 2015. PMID: 25572136 Free article.

7

Differential regulation of extracellular matrix protein expression in carcinoma-associated fibroblasts by TGF-β1 regulates cancer cell spreading but not adhesion.

Van Bockstal M, Lambein K, Van Gele M, De Vlieghere E, Limame R, Braems G, Van den Broecke R, Cocquyt V, Denys H, Bracke M, Libbrecht L, De Wever O. Van Bockstal M, et al. Among authors: lambein k. Oncoscience. 2014 Oct 15;1(10):634-48. doi: 10.18632/oncoscience.87. eCollection 2014. Oncoscience. 2014. PMID: 25593993 Free PMC article.

8

The Baader-Meinhof phenomenon in ductal carcinoma in situ of the breast.

Van Bockstal M, Libbrecht L, Floris G, Lambein K. Van Bockstal M, et al. Among authors: lambein k. Histopathology. 2016 Sep;69(3):522-3. doi: 10.1111/his.12977. Epub 2016 May 5. Histopathology. 2016. PMID: 27028714 No abstract available.

9

Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression.

Lambein K, Van Bockstal M, Vandemaele L, Van den Broecke R, Cocquyt V, Geenen S, Denys H, Libbrecht L. Lambein K, et al. Virchows Arch. 2017 Nov;471(5):575-587. doi: 10.1007/s00428-017-2161-8. Epub 2017 May 31. Virchows Arch. 2017. PMID: 28567637

10

Stromal inflammation, necrosis and HER2 overexpression in ductal carcinoma in situ of the breast: another causality dilemma?

Van Bockstal M, Libbrecht L, Floris G, Lambein K, Pinder S. Van Bockstal M, et al. Among authors: lambein k. Ann Oncol. 2017 Sep 1;28(9):2317. doi: 10.1093/annonc/mdx253. Ann Oncol. 2017. PMID: 28911076 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters